Financial results - NICOMED PLUS S.R.L.

Financial Summary - Nicomed Plus S.r.l.
Unique identification code: 29207757
Registration number: J13/2290/2011
Nace: 8622
Sales - Ron
44.766
Net Profit - Ron
26.407
Employee
5
The most important financial indicators for the company Nicomed Plus S.r.l. - Unique Identification Number 29207757: sales in 2023 was 44.766 euro, registering a net profit of 26.407 euro and having an average number of 5 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Nicomed Plus S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 11.325 23.881 24.596 28.907 28.401 35.554 38.226 34.697 60.775 44.766
Total Income - EUR 11.325 23.883 24.596 28.907 28.401 35.554 38.226 34.697 60.775 44.766
Total Expenses - EUR 11.801 12.518 11.367 12.072 16.062 22.291 19.311 15.439 24.293 17.912
Gross Profit/Loss - EUR -476 11.365 13.229 16.835 12.339 13.264 18.915 19.259 36.483 26.854
Net Profit/Loss - EUR -816 10.648 12.736 16.546 12.055 12.908 18.533 18.911 35.875 26.407
Employees 0 5 5 5 5 5 5 5 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -26.1%, from 60.775 euro in the year 2022, to 44.766 euro in 2023. The Net Profit decreased by -9.360 euro, from 35.875 euro in 2022, to 26.407 in the last year.

Check the financial reports for the company - Nicomed Plus S.r.l.

Rating financiar

Financial Rating -
Nicomed Plus S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Nicomed Plus S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nicomed Plus S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Nicomed Plus S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nicomed Plus S.r.l. - CUI 29207757

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 275 131 0 521 1.599 1.046 1.680 1.662 5.069 3.436
Current Assets 2.898 8.911 12.076 15.476 26.680 39.214 56.449 64.443 87.527 39.288
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 1.581 1.203 593 678 401 456 448 438 753 12.322
Cash 1.317 7.708 11.482 14.799 26.279 38.758 56.001 64.005 86.773 26.966
Shareholders Funds -2.503 8.125 11.402 15.234 27.010 39.395 57.181 65.176 91.443 41.761
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 5.676 918 800 762 1.269 925 947 929 1.153 963
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 39.288 euro in 2023 which includes Inventories of 0 euro, Receivables of 12.322 euro and cash availability of 26.966 euro.
The company's Equity was valued at 41.761 euro, while total Liabilities amounted to 963 euro. Equity decreased by -49.405 euro, from 91.443 euro in 2022, to 41.761 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Nicomed Plus S.r.l.

Comments - Nicomed Plus S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.